English
简体中文
Total: £ 56.28
Published Date: 2026-01-07 | Pages: 116 | Tables: 114 | Pharma & Healthcare
The global Aminopyrine API market was valued at US$ 31.59 million in 2025 and is anticipated to reach US$ 28.31 million by 2032, at a CAGR of -1.7% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Aminopyrine API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Aminopyrine API is a pyrazolone compound and a derivative of phenacetin, which itself also has anti-inflammatory and antipyretic effects. Aminopyrine (Aminophenazone, Amidopyrine, Pyramidon) is a non-narcotic analgesic. While this drug is inexpensive and highly effective, especially in treating rheumatic diseases, it also carries serious side effects, such as agranulocytosis, and in some cases, even fatal ones. In 2025, global Aminopyrine API production reached approximately 2.26 K MT. Global production capacity in 2025 is approximately 3 K MT. Aminopyrine API is a legacy pyrazolone antipyretic/analgesic. Upstream inputs typically include pyrazolone intermediates (e.g., 4-aminoantipyrine), amination/methylation-related reagents, process solvents/catalysts, plus EHS and QA materials. Supply tends to be concentrated among manufacturers capable of compliant large-scale production, including Shandong Xinhua Pharmaceutical Company Limited, Hebei Jiheng Pharmaceutical Co., Ltd, and Wuhan Wuyao. Downstream demand is mainly tied to compound antipyretic/analgesic injections/tablets in jurisdictions where use persists, as well as research/reference-standard channels.
Aminopyrine is a "historical drug" in the antipyretic and analgesic field, but due to its association with serious hematologic adverse reactions (such as agranulocytosis), it has been withdrawn from the market/banned or strictly restricted in most industrialized countries. Therefore, the global demand for aminopyrine API is relatively limited and highly susceptible to policy influences. At present, demand comes more from countries/regions where legal use still exists and from specific combination preparations (such as compound aminopyrine injections/related combination drugs).
This report delivers a comprehensive overview of the global Aminopyrine API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Aminopyrine API. The Aminopyrine API market size, estimates, and forecasts are provided in terms of sales volume (MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Aminopyrine API market comprehensively. Regional market sizes by Type, by Application, by Formulation, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Aminopyrine API manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Xinhua Pharmaceutical Company Limited
Jiheng Pharmaceutical Co., Ltd
Wuyao Pharmaceutical Co., Ltd
Haisen Pharma
Jinghua Pharmaceutical Co., Ltd
Vani Pharma Labs Limited
Jingfeng Pharmaceutical (Shandong) Co., Ltd
Pure Pharm Biotech
Chemcopia
Segment by Type
99% and Above
Below 99%
Segment by Formulation
Compound Injection
Tablets
Others
Segment by Nature of Demand
Maintenance Demand
Substitution-constrained Demand
Non-therapeutic Demand
Segment by Quality & Compliance Tier
GMP Pharmaceutical Grade
Technical Grade/Non-Registration Grade
by Application
Human Use
Veterinary Use
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Formulation, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Aminopyrine API manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Aminopyrine API sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Aminopyrine API Market Overview
1.1 Product Definition
1.2 Aminopyrine API by Type
1.2.1 Global Aminopyrine API Market Value by Type: 2025 vs 2032
1.2.2 99% and Above
1.2.3 Below 99%
1.3 Aminopyrine API by Formulation
1.3.1 Global Aminopyrine API Market Value by Formulation: 2025 vs 2032
1.3.2 Compound Injection
1.3.3 Tablets
1.3.4 Others
1.4 Aminopyrine API by Nature of Demand
1.4.1 Global Aminopyrine API Market Value by Nature of Demand: 2025 vs 2032
1.4.2 Maintenance Demand
1.4.3 Substitution-constrained Demand
1.4.4 Non-therapeutic Demand
1.5 Aminopyrine API by Quality & Compliance Tier
1.5.1 Global Aminopyrine API Market Value by Quality & Compliance Tier: 2025 vs 2032
1.5.2 GMP Pharmaceutical Grade
1.5.3 Technical Grade/Non-Registration Grade
1.6 Aminopyrine API by Application
1.6.1 Global Aminopyrine API Market Value by Application: 2025 vs 2032
1.6.2 Human Use
1.6.3 Veterinary Use
1.7 Global Aminopyrine API Market Size Estimates and Forecasts
1.7.1 Global Aminopyrine API Revenue 2021–2032
1.7.2 Global Aminopyrine API Sales 2021–2032
1.7.3 Global Aminopyrine API Market Average Price (2021–2032)
1.8 Assumptions and Limitations
2 Aminopyrine API Market Competition by Manufacturers
2.1 Global Aminopyrine API Sales Market Share by Manufacturers (2021–2026)
2.2 Global Aminopyrine API Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Aminopyrine API Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Aminopyrine API, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Aminopyrine API, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Aminopyrine API, Product Types and Applications
2.7 Global Key Manufacturers of Aminopyrine API, Date of Entry into the Industry
2.8 Global Aminopyrine API Market Competitive Situation and Trends
2.8.1 Global Aminopyrine API Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Aminopyrine API Players Market Share by Revenue
2.8.3 Global Aminopyrine API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Aminopyrine API Market Scenario by Region
3.1 Global Aminopyrine API Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Aminopyrine API Sales by Region: 2021–2032
3.2.1 Global Aminopyrine API Sales by Region: 2021–2026
3.2.2 Global Aminopyrine API Sales by Region: 2027–2032
3.3 Global Aminopyrine API Revenue by Region: 2021–2032
3.3.1 Global Aminopyrine API Revenue by Region: 2021–2026
3.3.2 Global Aminopyrine API Revenue by Region: 2027–2032
3.4 North America Aminopyrine API Market Facts & Figures by Country
3.4.1 North America Aminopyrine API Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Aminopyrine API Sales by Country (2021–2032)
3.4.3 North America Aminopyrine API Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Aminopyrine API Market Facts & Figures by Country
3.5.1 Europe Aminopyrine API Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Aminopyrine API Sales by Country (2021–2032)
3.5.3 Europe Aminopyrine API Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Aminopyrine API Market Facts & Figures by Region
3.6.1 Asia Pacific Aminopyrine API Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Aminopyrine API Sales by Region (2021–2032)
3.6.3 Asia Pacific Aminopyrine API Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Aminopyrine API Market Facts & Figures by Country
3.7.1 Latin America Aminopyrine API Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Aminopyrine API Sales by Country (2021–2032)
3.7.3 Latin America Aminopyrine API Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Aminopyrine API Market Facts & Figures by Country
3.8.1 Middle East and Africa Aminopyrine API Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Aminopyrine API Sales by Country (2021–2032)
3.8.3 Middle East and Africa Aminopyrine API Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Aminopyrine API Sales by Type (2021–2032)
4.1.1 Global Aminopyrine API Sales by Type (2021–2026)
4.1.2 Global Aminopyrine API Sales by Type (2027–2032)
4.1.3 Global Aminopyrine API Sales Market Share by Type (2021–2032)
4.2 Global Aminopyrine API Revenue by Type (2021–2032)
4.2.1 Global Aminopyrine API Revenue by Type (2021–2026)
4.2.2 Global Aminopyrine API Revenue by Type (2027–2032)
4.2.3 Global Aminopyrine API Revenue Market Share by Type (2021–2032)
4.3 Global Aminopyrine API Price by Type (2021–2032)
5 Segment by Application
5.1 Global Aminopyrine API Sales by Application (2021–2032)
5.1.1 Global Aminopyrine API Sales by Application (2021–2026)
5.1.2 Global Aminopyrine API Sales by Application (2027–2032)
5.1.3 Global Aminopyrine API Sales Market Share by Application (2021–2032)
5.2 Global Aminopyrine API Revenue by Application (2021–2032)
5.2.1 Global Aminopyrine API Revenue by Application (2021–2026)
5.2.2 Global Aminopyrine API Revenue by Application (2027–2032)
5.2.3 Global Aminopyrine API Revenue Market Share by Application (2021–2032)
5.3 Global Aminopyrine API Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Xinhua Pharmaceutical Company Limited
6.1.1 Xinhua Pharmaceutical Company Limited Company Information
6.1.2 Xinhua Pharmaceutical Company Limited Description and Business Overview
6.1.3 Xinhua Pharmaceutical Company Limited Aminopyrine API Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Xinhua Pharmaceutical Company Limited Aminopyrine API Product Portfolio
6.1.5 Xinhua Pharmaceutical Company Limited Recent Developments/Updates
6.2 Jiheng Pharmaceutical Co., Ltd
6.2.1 Jiheng Pharmaceutical Co., Ltd Company Information
6.2.2 Jiheng Pharmaceutical Co., Ltd Description and Business Overview
6.2.3 Jiheng Pharmaceutical Co., Ltd Aminopyrine API Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Jiheng Pharmaceutical Co., Ltd Aminopyrine API Product Portfolio
6.2.5 Jiheng Pharmaceutical Co., Ltd Recent Developments/Updates
6.3 Wuyao Pharmaceutical Co., Ltd
6.3.1 Wuyao Pharmaceutical Co., Ltd Company Information
6.3.2 Wuyao Pharmaceutical Co., Ltd Description and Business Overview
6.3.3 Wuyao Pharmaceutical Co., Ltd Aminopyrine API Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Wuyao Pharmaceutical Co., Ltd Aminopyrine API Product Portfolio
6.3.5 Wuyao Pharmaceutical Co., Ltd Recent Developments/Updates
6.4 Haisen Pharma
6.4.1 Haisen Pharma Company Information
6.4.2 Haisen Pharma Description and Business Overview
6.4.3 Haisen Pharma Aminopyrine API Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Haisen Pharma Aminopyrine API Product Portfolio
6.4.5 Haisen Pharma Recent Developments/Updates
6.5 Jinghua Pharmaceutical Co., Ltd
6.5.1 Jinghua Pharmaceutical Co., Ltd Company Information
6.5.2 Jinghua Pharmaceutical Co., Ltd Description and Business Overview
6.5.3 Jinghua Pharmaceutical Co., Ltd Aminopyrine API Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Jinghua Pharmaceutical Co., Ltd Aminopyrine API Product Portfolio
6.5.5 Jinghua Pharmaceutical Co., Ltd Recent Developments/Updates
6.6 Vani Pharma Labs Limited
6.6.1 Vani Pharma Labs Limited Company Information
6.6.2 Vani Pharma Labs Limited Description and Business Overview
6.6.3 Vani Pharma Labs Limited Aminopyrine API Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Vani Pharma Labs Limited Aminopyrine API Product Portfolio
6.6.5 Vani Pharma Labs Limited Recent Developments/Updates
6.7 Jingfeng Pharmaceutical (Shandong) Co., Ltd
6.7.1 Jingfeng Pharmaceutical (Shandong) Co., Ltd Company Information
6.7.2 Jingfeng Pharmaceutical (Shandong) Co., Ltd Description and Business Overview
6.7.3 Jingfeng Pharmaceutical (Shandong) Co., Ltd Aminopyrine API Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Jingfeng Pharmaceutical (Shandong) Co., Ltd Aminopyrine API Product Portfolio
6.7.5 Jingfeng Pharmaceutical (Shandong) Co., Ltd Recent Developments/Updates
6.8 Pure Pharm Biotech
6.8.1 Pure Pharm Biotech Company Information
6.8.2 Pure Pharm Biotech Description and Business Overview
6.8.3 Pure Pharm Biotech Aminopyrine API Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Pure Pharm Biotech Aminopyrine API Product Portfolio
6.8.5 Pure Pharm Biotech Recent Developments/Updates
6.9 Chemcopia
6.9.1 Chemcopia Company Information
6.9.2 Chemcopia Description and Business Overview
6.9.3 Chemcopia Aminopyrine API Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Chemcopia Aminopyrine API Product Portfolio
6.9.5 Chemcopia Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Aminopyrine API Industry Chain Analysis
7.2 Aminopyrine API Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Aminopyrine API Production Mode & Process Analysis
7.4 Aminopyrine API Sales and Marketing
7.4.1 Aminopyrine API Sales Channels
7.4.2 Aminopyrine API Distributors
7.5 Aminopyrine API Customer Analysis
8 Aminopyrine API Market Dynamics
8.1 Aminopyrine API Industry Trends
8.2 Aminopyrine API Market Drivers
8.3 Aminopyrine API Market Challenges
8.4 Aminopyrine API Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Aminopyrine API Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Aminopyrine API Market Value by Formulation (US$ Million), 2025 vs 2032
Table 3. Global Aminopyrine API Market Value by Nature of Demand (US$ Million), 2025 vs 2032
Table 4. Global Aminopyrine API Market Value by Quality & Compliance Tier (US$ Million), 2025 vs 2032
Table 5. Global Aminopyrine API Market Value by Application (US$ Million), 2025 vs 2032
Table 6. Global Aminopyrine API Market Competitive Situation by Manufacturers in 2025
Table 7. Global Aminopyrine API Sales (MT) of Key Manufacturers (2021–2026)
Table 8. Global Aminopyrine API Sales Market Share by Manufacturers (2021–2026)
Table 9. Global Aminopyrine API Revenue (US$ Million) by Manufacturers (2021–2026)
Table 10. Global Aminopyrine API Revenue Share by Manufacturers (2021–2026)
Table 11. Global Market Aminopyrine API Average Price (US$/kg) of Key Manufacturers (2021–2026)
Table 12. Global Key Players of Aminopyrine API, Industry Ranking, 2023 vs 2024 vs 2025
Table 13. Global Key Manufacturers of Aminopyrine API, Manufacturing Sites and Headquarters
Table 14. Global Key Manufacturers of Aminopyrine API, Product Types and Applications
Table 15. Global Key Manufacturers of Aminopyrine API, Date of Entry into the Industry
Table 16. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Aminopyrine API Companies by Tier (Tier 1, Tier 2, Tier 3), based on Aminopyrine API Revenue, 2025
Table 18. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 19. Global Aminopyrine API Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 20. Global Aminopyrine API Sales by Region (MT), 2021–2026
Table 21. Global Aminopyrine API Sales Market Share by Region (2021–2026)
Table 22. Global Aminopyrine API Sales by Region (MT), 2027–2032
Table 23. Global Aminopyrine API Sales Market Share by Region (2027–2032)
Table 24. Global Aminopyrine API Revenue by Region (US$ Million), 2021–2026
Table 25. Global Aminopyrine API Revenue Market Share by Region (2021–2026)
Table 26. Global Aminopyrine API Revenue by Region (US$ Million), 2027–2032
Table 27. Global Aminopyrine API Revenue Market Share by Region (2027–2032)
Table 28. North America Aminopyrine API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. North America Aminopyrine API Sales by Country (MT), 2021–2026
Table 30. North America Aminopyrine API Sales by Country (MT), 2027–2032
Table 31. North America Aminopyrine API Revenue by Country (US$ Million), 2021–2026
Table 32. North America Aminopyrine API Revenue by Country (US$ Million), 2027–2032
Table 33. Europe Aminopyrine API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 34. Europe Aminopyrine API Sales by Country (MT), 2021–2026
Table 35. Europe Aminopyrine API Sales by Country (MT), 2027–2032
Table 36. Europe Aminopyrine API Revenue by Country (US$ Million), 2021–2026
Table 37. Europe Aminopyrine API Revenue by Country (US$ Million), 2027–2032
Table 38. Asia Pacific Aminopyrine API Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 39. Asia Pacific Aminopyrine API Sales by Region (MT), 2021–2026
Table 40. Asia Pacific Aminopyrine API Sales by Region (MT), 2027–2032
Table 41. Asia Pacific Aminopyrine API Revenue by Region (US$ Million), 2021–2026
Table 42. Asia Pacific Aminopyrine API Revenue by Region (US$ Million), 2027–2032
Table 43. Latin America Aminopyrine API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 44. Latin America Aminopyrine API Sales by Country (MT), 2021–2026
Table 45. Latin America Aminopyrine API Sales by Country (MT), 2027–2032
Table 46. Latin America Aminopyrine API Revenue by Country (US$ Million), 2021–2026
Table 47. Latin America Aminopyrine API Revenue by Country (US$ Million), 2027–2032
Table 48. Middle East and Africa Aminopyrine API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Middle East and Africa Aminopyrine API Sales by Country (MT), 2021–2026
Table 50. Middle East and Africa Aminopyrine API Sales by Country (MT), 2027–2032
Table 51. Middle East and Africa Aminopyrine API Revenue by Country (US$ Million), 2021–2026
Table 52. Middle East and Africa Aminopyrine API Revenue by Country (US$ Million), 2027–2032
Table 53. Global Aminopyrine API Sales (MT) by Type (2021–2026)
Table 54. Global Aminopyrine API Sales (MT) by Type (2027–2032)
Table 55. Global Aminopyrine API Sales Market Share by Type (2021–2026)
Table 56. Global Aminopyrine API Sales Market Share by Type (2027–2032)
Table 57. Global Aminopyrine API Revenue (US$ Million) by Type (2021–2026)
Table 58. Global Aminopyrine API Revenue (US$ Million) by Type (2027–2032)
Table 59. Global Aminopyrine API Revenue Market Share by Type (2021–2026)
Table 60. Global Aminopyrine API Revenue Market Share by Type (2027–2032)
Table 61. Global Aminopyrine API Price (US$/kg) by Type (2021–2026)
Table 62. Global Aminopyrine API Price (US$/kg) by Type (2027–2032)
Table 63. Global Aminopyrine API Sales (MT) by Application (2021–2026)
Table 64. Global Aminopyrine API Sales (MT) by Application (2027–2032)
Table 65. Global Aminopyrine API Sales Market Share by Application (2021–2026)
Table 66. Global Aminopyrine API Sales Market Share by Application (2027–2032)
Table 67. Global Aminopyrine API Revenue (US$ Million) by Application (2021–2026)
Table 68. Global Aminopyrine API Revenue (US$ Million) by Application (2027–2032)
Table 69. Global Aminopyrine API Revenue Market Share by Application (2021–2026)
Table 70. Global Aminopyrine API Revenue Market Share by Application (2027–2032)
Table 71. Global Aminopyrine API Price (US$/kg) by Application (2021–2026)
Table 72. Global Aminopyrine API Price (US$/kg) by Application (2027–2032)
Table 73. Xinhua Pharmaceutical Company Limited Company Information
Table 74. Xinhua Pharmaceutical Company Limited Description and Business Overview
Table 75. Xinhua Pharmaceutical Company Limited Aminopyrine API Sales (MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 76. Xinhua Pharmaceutical Company Limited Aminopyrine API Product
Table 77. Xinhua Pharmaceutical Company Limited Recent Developments/Updates
Table 78. Jiheng Pharmaceutical Co., Ltd Company Information
Table 79. Jiheng Pharmaceutical Co., Ltd Description and Business Overview
Table 80. Jiheng Pharmaceutical Co., Ltd Aminopyrine API Sales (MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 81. Jiheng Pharmaceutical Co., Ltd Aminopyrine API Product
Table 82. Jiheng Pharmaceutical Co., Ltd Recent Developments/Updates
Table 83. Wuyao Pharmaceutical Co., Ltd Company Information
Table 84. Wuyao Pharmaceutical Co., Ltd Description and Business Overview
Table 85. Wuyao Pharmaceutical Co., Ltd Aminopyrine API Sales (MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 86. Wuyao Pharmaceutical Co., Ltd Aminopyrine API Product
Table 87. Wuyao Pharmaceutical Co., Ltd Recent Developments/Updates
Table 88. Haisen Pharma Company Information
Table 89. Haisen Pharma Description and Business Overview
Table 90. Haisen Pharma Aminopyrine API Sales (MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 91. Haisen Pharma Aminopyrine API Product
Table 92. Haisen Pharma Recent Developments/Updates
Table 93. Jinghua Pharmaceutical Co., Ltd Company Information
Table 94. Jinghua Pharmaceutical Co., Ltd Description and Business Overview
Table 95. Jinghua Pharmaceutical Co., Ltd Aminopyrine API Sales (MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 96. Jinghua Pharmaceutical Co., Ltd Aminopyrine API Product
Table 97. Jinghua Pharmaceutical Co., Ltd Recent Developments/Updates
Table 98. Vani Pharma Labs Limited Company Information
Table 99. Vani Pharma Labs Limited Description and Business Overview
Table 100. Vani Pharma Labs Limited Aminopyrine API Sales (MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 101. Vani Pharma Labs Limited Aminopyrine API Product
Table 102. Vani Pharma Labs Limited Recent Developments/Updates
Table 103. Jingfeng Pharmaceutical (Shandong) Co., Ltd Company Information
Table 104. Jingfeng Pharmaceutical (Shandong) Co., Ltd Description and Business Overview
Table 105. Jingfeng Pharmaceutical (Shandong) Co., Ltd Aminopyrine API Sales (MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 106. Jingfeng Pharmaceutical (Shandong) Co., Ltd Aminopyrine API Product
Table 107. Jingfeng Pharmaceutical (Shandong) Co., Ltd Recent Developments/Updates
Table 108. Pure Pharm Biotech Company Information
Table 109. Pure Pharm Biotech Description and Business Overview
Table 110. Pure Pharm Biotech Aminopyrine API Sales (MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 111. Pure Pharm Biotech Aminopyrine API Product
Table 112. Pure Pharm Biotech Recent Developments/Updates
Table 113. Chemcopia Company Information
Table 114. Chemcopia Description and Business Overview
Table 115. Chemcopia Aminopyrine API Sales (MT), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 116. Chemcopia Aminopyrine API Product
Table 117. Chemcopia Recent Developments/Updates
Table 118. Key Raw Materials Lists
Table 119. Raw Materials Key Suppliers Lists
Table 120. Aminopyrine API Distributors List
Table 121. Aminopyrine API Customers List
Table 122. Aminopyrine API Market Trends
Table 123. Aminopyrine API Market Drivers
Table 124. Aminopyrine API Market Challenges
Table 125. Aminopyrine API Market Restraints
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. Product Picture of Aminopyrine API
Figure 2. Global Aminopyrine API Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Aminopyrine API Market Share by Type: 2025 & 2032
Figure 4. 99% and Above Product Picture
Figure 5. Below 99% Product Picture
Figure 6. Global Aminopyrine API Market Value by Formulation (US$ Million), 2021–2032
Figure 7. Global Aminopyrine API Market Share by Formulation: 2025 vs 2032
Figure 8. Compound Injection Product Picture
Figure 9. Tablets Product Picture
Figure 10. Others Product Picture
Figure 11. Global Aminopyrine API Market Value by Nature of Demand (US$ Million), 2021–2032
Figure 12. Global Aminopyrine API Market Share by Nature of Demand: 2025 vs 2032
Figure 13. Maintenance Demand Product Picture
Figure 14. Substitution-constrained Demand Product Picture
Figure 15. Non-therapeutic Demand Product Picture
Figure 16. Global Aminopyrine API Market Value by Quality & Compliance Tier (US$ Million), 2021–2032
Figure 17. Global Aminopyrine API Market Share by Quality & Compliance Tier: 2025 vs 2032
Figure 18. GMP Pharmaceutical Grade Product Picture
Figure 19. Technical Grade/Non-Registration Grade Product Picture
Figure 20. Global Aminopyrine API Market Value by Application (US$ Million), 2021–2032
Figure 21. Global Aminopyrine API Market Share by Application: 2025 & 2032
Figure 22. Human Use
Figure 23. Veterinary Use
Figure 24. Global Aminopyrine API Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 25. Global Aminopyrine API Market Size (US$ Million), 2021–2032
Figure 26. Global Aminopyrine API Sales (MT), 2021–2032
Figure 27. Global Aminopyrine API Average Price (US$/kg), 2021–2032
Figure 28. Aminopyrine API Report Years Considered
Figure 29. Aminopyrine API Sales Share by Manufacturers in 2025
Figure 30. Global Aminopyrine API Revenue Share by Manufacturers in 2025
Figure 31. Top 5 and Top 10 Global Aminopyrine API Players: Market Share by Revenue in Aminopyrine API in 2025
Figure 32. Aminopyrine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 33. Global Aminopyrine API Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 34. North America Aminopyrine API Sales Market Share by Country (2021–2032)
Figure 35. North America Aminopyrine API Revenue Market Share by Country (2021–2032)
Figure 36. United States Aminopyrine API Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Canada Aminopyrine API Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Europe Aminopyrine API Sales Market Share by Country (2021–2032)
Figure 39. Europe Aminopyrine API Revenue Market Share by Country (2021–2032)
Figure 40. Germany Aminopyrine API Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. France Aminopyrine API Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. U.K. Aminopyrine API Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Italy Aminopyrine API Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Russia Aminopyrine API Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Asia Pacific Aminopyrine API Sales Market Share by Region (2021–2032)
Figure 46. Asia Pacific Aminopyrine API Revenue Market Share by Region (2021–2032)
Figure 47. China Aminopyrine API Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Japan Aminopyrine API Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. South Korea Aminopyrine API Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. India Aminopyrine API Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Australia Aminopyrine API Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. China Taiwan Aminopyrine API Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Southeast Asia Aminopyrine API Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Latin America Aminopyrine API Sales Market Share by Country (2021–2032)
Figure 55. Latin America Aminopyrine API Revenue Market Share by Country (2021–2032)
Figure 56. Mexico Aminopyrine API Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Brazil Aminopyrine API Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Argentina Aminopyrine API Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Colombia Aminopyrine API Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. Middle East and Africa Aminopyrine API Sales Market Share by Country (2021–2032)
Figure 61. Middle East and Africa Aminopyrine API Revenue Market Share by Country (2021–2032)
Figure 62. Turkey Aminopyrine API Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. Saudi Arabia Aminopyrine API Revenue Growth Rate (US$ Million), 2021–2032
Figure 64. UAE Aminopyrine API Revenue Growth Rate (US$ Million), 2021–2032
Figure 65. Global Sales Market Share of Aminopyrine API by Type (2021–2032)
Figure 66. Global Revenue Market Share of Aminopyrine API by Type (2021–2032)
Figure 67. Global Aminopyrine API Price (US$/kg) by Type (2021–2032)
Figure 68. Global Sales Market Share of Aminopyrine API by Application (2021–2032)
Figure 69. Global Revenue Market Share of Aminopyrine API by Application (2021–2032)
Figure 70. Global Aminopyrine API Price (US$/kg) by Application (2021–2032)
Figure 71. Aminopyrine API Value Chain
Figure 72. Channels of Distribution (Direct Vs Distribution)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
